Upstream Bio (UPB) Earnings Analysis
Upstream Bio (UPB) has no confirmed upcoming earnings date. Last quarter (2026-03-26) it missed with EPS -0.79 USD vs -0.73 USD est (-8.2%). It has beaten estimates in 0/3 recent quarters (0%). Trailing P/E -2.26.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does UPB next report earnings?
No confirmed upcoming earnings date is currently scheduled for UPB. This page updates as the calendar is published.
UPB earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-03-26 | -0.79 USD | -0.73 USD | -8.2% | Miss |
| 2025-03-13 | -1.59 USD | -0.56 USD | -183.9% | Miss |
| 2024-11-07 | -6.96 USD | -0.53526 USD | -1200.3% | Miss |
Beat rate: 0/3 (0%) over reported quarters with consensus data.
UPB valuation and analyst view
| Trailing P/E | -2.26 |
|---|---|
| Trailing EPS | -2.88528 USD |
| Price / book | 1.18 |
| Dividend yield | 0.00% |
| Market cap | 0.35B |
| Analyst consensus | Hold (1 buy / 2 hold / 0 sell) |
| Avg price target | 37.67 USD |
Related research pages
Frequently asked questions
When is Upstream Bio (UPB)'s next earnings date?
No confirmed upcoming earnings date is currently scheduled for UPB. This page updates as the calendar is published.
Did UPB beat earnings last quarter?
In its 2026-03-26 report, UPB posted EPS of -0.79 USD versus a -0.73 USD estimate — a miss of 8.2%.
What is UPB's earnings track record?
Over the last 3 reported quarters with consensus data, UPB beat estimates 0 times (0%).
What is UPB's current P/E ratio and EPS?
UPB trades at a trailing P/E of -2.26 on trailing EPS of -2.885280858341423 USD.
What do analysts rate UPB?
Analyst consensus is "Hold" across 3 ratings (0 strong buy, 1 buy, 2 hold, 0 sell, 0 strong sell). Average 12-month price target: 37.67 USD.